The susceptibility of congenitally athymic rats to Mycobacterium leprae infection has been investigated. Following inoculation of small numbers of M. leprae (5 X 10(3] into the foot pad, the organisms replicated and attained a maximum of 2.6 X 10(8) per foot pad at 294 days; there was limited dissemination to the tail. In similarly inoculated neonatally thymectomized Lewis rats (NTLRs) a ceiling of 2 X 10(7) organisms was reached. When a larger inoculum (10(7] was given, the number of bacilli in athymic rat foot pads peaked at 6.7 X 10(8) and after approximately 240 days a plateau of between 2 X 10(8) and 6 X 10(8) per foot pad was reached. Dissemination to superficial tissues occurred approximately nine months after inoculation, when significant numbers of bacilli were recovered from the foot pads, ears, snout, and tail. Following intravenous inoculation of 10(7) M. leprae into athymic rats, significant numbers of bacilli were recovered from the superficial tissues by 300 days post inoculation. The numbers of organisms reached a plateau of about 10(8) by one year. Autopsy of infected animals from 1-2 years after inoculation revealed no gross abnormalities except for a purulent bronchitis and bronchopneumonia. Although normal grossly, the ears, tail, snout and foot pads showed a varying degree of infiltration by histiocytes. In some this was almost imperceptible, in others there were large accumulations of foamy macrophages reminiscent of lepromatous leprosy. The numbers of mycobacteria present in Fite stains ranged from 2+ (several organisms or clusters of organisms) to 5+ (very numerous). The lymph nodes contained numerous non-caseating granulomata composed of activated macrophages which contained large (4+) or very large (5+) numbers of bacilli. Mycobacteria were present in the cells of the mononuclear-phagocyte series in the liver and spleen of animals killed 12-15 months post inoculation, but were absent from these cells in animals killed later. M. leprae were also numerous in the smooth muscle of the scrotum. It is concluded that congenitally athymic rats are highly susceptible to M. leprae infection. Despite their lack of thymic-dependent T cell function, it appears that they possess the defense mechanism(s) capable of limiting the infection.

Download full-text PDF

Source

Publication Analysis

Top Keywords

congenitally athymic
12
athymic rats
12
foot pad
12
foot pads
12
numbers bacilli
12
athymic rat
8
mycobacterium leprae
8
leprae infection
8
108 foot
8
organisms reached
8

Similar Publications

European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia.

J Allergy Clin Immunol

December 2024

Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Infection Immunity and Inflammation Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.

Article Synopsis
  • Congenital athymia is a serious condition that affects the immune system and makes babies very sick because their thymus (an important organ for immunity) doesn't work properly.
  • Babies with this condition are very vulnerable to infections and sometimes have other health issues.
  • The best treatment is a special surgery called thymus transplantation, and catching this condition early helps kids stay healthier.
View Article and Find Full Text PDF
Article Synopsis
  • - Congenital athymia is a rare condition affecting T-lymphocyte levels, requiring thymus transplantation, and is often detected early through newborn screening for severe combined immunodeficiency (SCID).
  • - Parents of infants identified with suspected athymia expressed that they were not informed of this diagnosis until weeks after initial screening results, highlighting a gap in timely communication and information access during the diagnostic process.
  • - A proposal was made for a roadmap that provides easily understandable, real-time information for parents, aiming to enhance their journey through diagnosis and potentially applicable to other rare diseases, emphasizing the importance of parental involvement and public engagement in healthcare.
View Article and Find Full Text PDF
Article Synopsis
  • CHARGE syndrome, caused by mutations in the CHD7 gene, can lead to severe immunodeficiency and is treated through options like cultured thymus tissue implantation (CTTI) and hematopoietic cell transplantation (HCT).
  • A study at Kyushu University analyzed outcomes of four patients post-non-conditioned cord blood transplantation (CBT) and compared them to eight other cases, observing a notable improvement in immune recovery and survival rates.
  • Results showed a 100% one-year survival rate for patients receiving non-conditioned HCT, with successful naïve T cell reconstitution, suggesting that this method is an effective temporary solution for newborns awaiting a more definitive immunological treatment.
View Article and Find Full Text PDF

Objectives: Thymus implantation is a recently FDA-approved therapy for congenital athymia. Patients receiving thymus implantation develop a functional but incomplete T cell compartment. Our objective was to develop a mouse model to study clinical thymus implantation in congenital athymia and to optimise implantation procedures to maximise T cell education and expansion of naïve T cells.

View Article and Find Full Text PDF

Impact of newborn screening for SCID on the management of congenital athymia.

J Allergy Clin Immunol

January 2024

Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Infection, Immunity and Inflammation Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, United Kingdom. Electronic address:

Background: Newborn screening (NBS) programs for severe combined immunodeficiency facilitate early diagnosis of severe combined immunodeficiency and promote early treatment with hematopoietic stem cell transplantation, resulting in improved clinical outcomes. Infants with congenital athymia are also identified through NBS because of severe T-cell lymphopenia. With the expanding introduction of NBS programs, referrals of athymic patients for treatment with thymus transplantation have recently increased at Great Ormond Street Hospital (GOSH) (London, United Kingdom).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!